1. Home
  2. WEST vs DRUG Comparison

WEST vs DRUG Comparison

Compare WEST & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westrock Coffee Company

WEST

Westrock Coffee Company

HOLD

Current Price

$8.08

Market Cap

741.4M

ML Signal

HOLD

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

HOLD

Current Price

$73.10

Market Cap

744.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WEST
DRUG
Founded
2009
2019
Country
United States
United States
Employees
1393
N/A
Industry
Beverages (Production/Distribution)
Pharmaceuticals and Biotechnology
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
741.4M
744.9M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
WEST
DRUG
Price
$8.08
$73.10
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$7.00
$129.25
AVG Volume (30 Days)
434.5K
229.3K
Earning Date
05-07-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$11.27
N/A
Revenue Next Year
$10.66
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.59
$32.50
52 Week High
$10.19
$123.75

Technical Indicators

Market Signals
Indicator
WEST
DRUG
Relative Strength Index (RSI) 54.38 49.29
Support Level $7.73 $71.39
Resistance Level $8.54 $77.16
Average True Range (ATR) 0.43 4.06
MACD 0.10 -0.21
Stochastic Oscillator 77.36 30.38

Price Performance

Historical Comparison
WEST
DRUG

About WEST Westrock Coffee Company

Westrock Coffee Co is an integrated coffee, tea, flavors, extracts, and ingredients solutions provider mainly in the United States. Additionally, it offers coffee sourcing, supply chain management, product development, roasting, packaging, and distribution services to retail, foodservice, restaurant, convenience store, travel center, non-commercial account, and hospitality industries around the world. The company's reportable segments are: Beverage Solutions and Sustainable Sourcing and Traceability. It generates maximum revenue from the Beverage Solutions segment, which offers beverage solutions, including coffee, tea, flavors, extracts, and ingredients. Geographically, the company generates maximum revenue from its business in the United States and the rest from other countries.

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: